| First Author | Cao XJ | Year | 2018 |
| Journal | Biochem Biophys Res Commun | Volume | 503 |
| Issue | 3 | Pages | 1356-1363 |
| PubMed ID | 30007438 | Mgi Jnum | J:270330 |
| Mgi Id | MGI:6276698 | Doi | 10.1016/j.bbrc.2018.07.048 |
| Citation | Cao XJ, et al. (2018) TLR4 mediates high-fat diet induced physiological changes in mice via attenuating PPARgamma/ABCG1 signaling pathway. Biochem Biophys Res Commun 503(3):1356-1363 |
| abstractText | High-fat diet (HFD) is known to promote atherosclerosis which accelerates the development of atherosclerotic cardiovascular diseases. Vascular dysfunction characterized by inflammation and lipid accumulation is common in atherosclerosis caused by HFD. The specific effects of HFD on blood vessels and the underlying mechanisms need to be further clarified. Toll-like receptor 4 (TLR4) is a key contributing factor in atherosclerosis and TLR4 deficiency protects vascular smooth muscle cells against inflammatory responses and lipid accumulation in vitro. However, the physiological significance of TLR4 signaling in HFD-induced changes is unknown. In this study, we observed that HFD feeding increased body weight, circulating inflammatory cytokines and lipid accumulation in the aorta of wild-type mice but apart from increasing body weight, did not affect the TLR4 knockout mice. TLR4 expression increased significantly in the arterial walls after receiving HFD treatment, while that of the co-localizing PPARgamma and ABCG1 markedly decreased. TLR4 deficiency reversed the HFD-induced attenuation of PPARgamma and ABCG1. In conclusion, TLR4 mediates HFD induced increase in body weight, inflammation and aortic lipid accumulation through, at least partly, the PPARgamma/ABCG1 signaling pathway. Therefore, interfering with TLR4 signaling is a viable therapeutic option in diet induced atherosclerosis. |
